Amount Raised
£37 Million
Round Type
Seed
Description
Birmingham-based UK Innovation & Science Seed Fund (UKI2S) has added an extra £37m to its patient capital fund to invest in seed-stage startups operating in areas including synthetic biology, fusion energy and defence.
Who else raised in Venture Capital and Biotechnology around the same time
Companies in the same sectors as UKI2S that raised within 45 days of this round, from Fundz verified event records.
- Telesair raised $23M on September 1, 2022.
- Nutromics raised $14M (Funding Round) on September 8, 2022.
- Photys Therapeutics raised $75M (Series A) on September 8, 2022.
- Tetra Bio-Pharma Inc. raised an undisclosed amount (Funding Round) on September 8, 2022.
- Kuria Therapeutics raised an undisclosed amount (Funding Round) on September 8, 2022.
- Autobahn Therapeutics raised an undisclosed amount (Funding Round) on September 8, 2022.
Who to call at UKI2S, and when
A new round usually means UKI2S is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day UKI2S raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at UKI2S, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at UKI2S. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment UKI2S raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
UKI2S raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.